Literature DB >> 32430328

Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?

Kenji Hashimoto1.   

Abstract

Entities:  

Year:  2020        PMID： 32430328      PMCID： PMC7260938          DOI： 10.1073/pnas.2001264117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder.

Authors:  Gihyun Yoon; Ismene L Petrakis; John H Krystal
Journal:  JAMA Psychiatry       Date:  2019-03-01       Impact factor: 21.596

2.  Lack of Opioid System in the Antidepressant Actions of Ketamine.

Authors:  Kai Zhang; Kenji Hashimoto
Journal:  Biol Psychiatry       Date:  2018-12-10       Impact factor: 13.382

3.  Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.

Authors:  Nolan R Williams; Boris D Heifets; Brandon S Bentzley; Christine Blasey; Keith D Sudheimer; Jessica Hawkins; David M Lyons; Alan F Schatzberg
Journal:  Mol Psychiatry       Date:  2019-08-29       Impact factor: 15.992

Review 4.  Ketamine: A Paradigm Shift for Depression Research and Treatment.

Authors:  John H Krystal; Chadi G Abdallah; Gerard Sanacora; Dennis S Charney; Ronald S Duman
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

5.  Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Authors:  Nolan R Williams; Boris D Heifets; Christine Blasey; Keith Sudheimer; Jaspreet Pannu; Heather Pankow; Jessica Hawkins; Justin Birnbaum; David M Lyons; Carolyn I Rodriguez; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2018-08-29       Impact factor: 18.112

Review 6.  The recent progress in animal models of depression.

Authors:  Qingzhong Wang; Matthew A Timberlake; Kevin Prall; Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-04-08       Impact factor: 5.067

7.  Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents.

Authors:  Matthew E Klein; Joshua Chandra; Salma Sheriff; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-15       Impact factor: 11.205

8.  Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress.

Authors:  Kai Zhang; Yuko Fujita; Lijia Chang; Youge Qu; Yaoyu Pu; Siming Wang; Yukihiko Shirayama; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2019-09-17       Impact factor: 6.222

Review 9.  Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.

Authors:  Kenji Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-11       Impact factor: 5.188

Review 10.  Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.

Authors:  Chun Yang; Jianjun Yang; Ailin Luo; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2019-11-07       Impact factor: 6.222
  10 in total
  5 in total

1.  Reply to Hashimoto: Ketamine is not an opioid but requires opioid system for antidepressant actions.

Authors:  Roberto Malinow; Matthew E Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-19       Impact factor: 11.205

2.  Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.

Authors:  Giovanni Martinotti; Stefania Chiappini; Mauro Pettorruso; Alessio Mosca; Andrea Miuli; Francesco Di Carlo; Giacomo D'Andrea; Roberta Collevecchio; Ilenia Di Muzio; Stefano L Sensi; Massimo Di Giannantonio
Journal:  Brain Sci       Date:  2021-06-27

3.  Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat.

Authors:  Christien Bowman; Ulrike Richter; Christopher R Jones; Claus Agerskov; Kjartan Frisch Herrik
Journal:  Front Psychiatry       Date:  2022-01-27       Impact factor: 4.157

4.  A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice.

Authors:  Li Ma; Long Wang; Lijia Chang; Jiajing Shan; Youge Qu; Xingming Wang; Xiayun Wan; Yuko Fujita; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2022-09-28       Impact factor: 7.989

Review 5.  Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.

Authors:  Yan Wei; Lijia Chang; Kenji Hashimoto
Journal:  Mol Psychiatry       Date:  2021-05-07       Impact factor: 15.992
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.